CRT 2026

TRANSCATHETER ELECTROSURGERY | BEYOND LEAFLET MODIFICATION

Moderator(s)

• 

  Robert J. Lederman, MD

  Senior Investigator, Chief, Laboratory of Cardiovascular Intervention
  National Institutes of Health/National Heart, Lung, and Blood Institute
  Bethesda, Maryland, United States

  Disclosure(s): National Institutes of Health: Grant/Research Support (Ongoing), I am co-inventor on patent applications assigned to NIH (my employer) (Ongoing)
• 

  Jeremy D. Rier, DO

  Interventional Cardiologist
  WellSpan Health

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Karim Al-Azizi, MD, FACC, FSCAI, FESC

  Medical Director, Cardiac Catheterization Laboratories
  The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
  Frisco, Texas, United States

  Disclosure information not submitted.
• 

  Jeremiah P. Depta, MD, MPHS, MBA, FACC, FSCAI

  Medical Director of the Cardiac Catheterization Laboratory and Structural heart Disease
  Medical College of Wisconsin/Froedtert Hospital
  Milwaukee, Wisconsin, United States

  Disclosure(s): Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Abdallah El Sabbagh, MD

  Interventional Cardiologist
  Mayo Clinic
  Jacksonville, Florida, United States

  Disclosure(s): No financial relationships to disclose
• 

  Neil P. Fam, MD

  Interventional Cardiology
  St. Michael's Hospital

  Disclosure(s): Abbott, Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  James McCabe, MD

  Section Chief, Interventional Cardiology
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.